Garcia, MJ, Riestra, S, Amiot, A, Julsgaard, M, de la Filia, IG, Calafat, M, Aguas, M, de la Pena, L, Roig, C, Caballol, B, Casanova, MJ, Farkas, K, Boysen, T, Bujanda, L, Cuaran, C, Dobru, D, Fousekis, F, Gargallo-Puyuelo, CJ, Savarino, E, Calvet, X, Huguet, JM, Kupcinskas, L, López-Cardona, J, Raine, T, van Oostrom, J, Gisbert, JP, Chaparro, M. Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study). ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2024; 59(10)DOI:10.1111/apt.17938. PMID:38445785. IF:6.700(Q1/1D).

Gómez-Labrador, C, Ricart, E, Iborra, M, Iglesias, E, Martín-Arranz, MD, de Castro, L, De Francisco, R, García-Alonso, FJ, Sanahuja, A, Gargallo-Puyuelo, CJ, Mesonero, F, Casanova, MJ, Mañosa, M, Rivero, M, Calvo, M, Sierra-Ausin, M, González-Muñoza, C, Calvet, X, García-López, S, Guardiola, J, García, LA, Márquez-Mosquera, L, Gutiérrez, A, Zabana, Y, Navarro-Llavat, M, Poyatos, RL, Piqueras, M, Torrealba, L, Bermejo, F, Ponferrada-Díaz, A, Pérez-Calle, JL, Barreiro-de Acosta, M, Tejido, C, Cabriada, JL, Marín-Jiménez, I, Roncero, O, Ber, Y, Fernández-Salazar, L, Aler, BC, Lucendo, AJ, Llaó, J, Bujanda, L, Villafranca, CM, Domènech, E, Chaparro, M, Gisbert, JP. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA. Pharmaceutics. 2024; 16(5)DOI:10.3390/pharmaceutics16050629. PMID:38794292. IF:5.500(Q1/1D).

Manosa, M, Riviere, P, de Greef, I, Oller, B, Roig, C, Calafat, M, Garcia-Planella, E, Laharie, D, Ferrante, M, Domenech, E. Long-term risk of delayed postoperative Crohn's disease recurrence in patients with no or mild endoscopic recurrence at first assessment. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54(8)DOI:10.1111/eci.14219. PMID:38647188. IF:3.600(Q1/2D).

Garcia-Guix, M, Ardevol, A, Sapena, V, Alvarado-Tápias, E, Huertas, A, Brujats, A, Fajardo, J, Cuyas, B, Poca, M, Guarner, C, Torras, X, Escorsell, A, Villanueva, C. Influence of further decompensation on survival across clinical stages of decompensated cirrhosis: The role of portal hypertension and HVPG changes. LIVER INTERNATIONAL. 2024; 44(8)DOI:10.1111/liv.15937. PMID:38634685. IF:5.200(Q1/2D).

Dunn, W, Li, YM, Singal, AK, Simonetto, DA, Diaz, LA, Idalsoaga, F, Ayares, G, Arnold, J, Ayala-Valverde, M, Perez, D, Gomez, J, Escarate, R, Fuentes-Lopez, E, Ramirez-Cadiz, C, Morales-Arraez, D, Zhang, W, Qian, SV, Ahn, JC, Buryska, S, Mehta, H, Dunn, N, Waleed, M, Stefanescu, H, Bumbu, A, Horhat, A, Attar, B, Agrawal, R, Cabezas, J, Echavaria, V, Cuyas, B, Poca, M, Soriano, G, Sarin, SK, Maiwall, R, Jalal, PK, Higuera-de-la-Tijera, F, Kulkarni, AV, Rao, PN, Guerra-Salazar, P, Skladany, L, Kubanek, N, Prado, V, Clemente-Sanchez, A, Rincon, D, Haider, T, Chacko, KR, Romero, GA, Pollarsky, FD, Restrepo, JC, Toro, LG, Yaquich, P, Mendizabal, M, Garrido, ML, Marciano, S, Dirchwolf, M, Vargas, V, Jimenez, C, Hudson, D, Garcia-Tsao, G, Ortiz, G, Abraldes, JG, Kamath, PS, Arrese, M, Shah, VH, Bataller, R, Arab, JP. An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study. HEPATOLOGY. 2024; 80(5)DOI:10.1097/HEP.0000000000000883. PMID:38607809. IF:15.800(Q1/1D).

D'Amico, G, Zipprich, A, Villanueva, C, Sordà, JA, Morillas, RM, Garcovich, M, Retortillo, MG, Martinez, J, Cales, P, D'Amico, M, Dollinger, M, García-Guix, M, Ballerga, EG, Tsochatzis, E, Cirera, I, Albillos, A, Roquin, G, Pasta, L, Colomo, A, Daruich, J, Canete, N, Boursier, J, Dallio, M, Gasbarrini, A, Iacobellis, A, Gobbo, G, Merli, M, Federico, A, Baroni, GS, Pozzoni, P, Addario, L, Chessa, L, Ridola, L, Garcia-Tsao, G. Further decompensation in cirrhosis. Results of a large multicenter cohort study supporting Baveno VII statements. HEPATOLOGY. 2024; 79(4)DOI:10.1097/HEP.0000000000000652. PMID:37916970. IF:15.800(Q1/1D).